Jeffrey A. Anderson, VP, Clinical & Regulatory at REVA Medical, Inc. (RVA), sold 2,500 shares at $6.56 ($16K) on 2012-05-30, disclosed to the SEC on 2012-05-31.
Open-market sale of $16k RVA by VP, Clinical & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RVA | SELL | 2012-06-14 | $31K | — | Filing → |
| RVA | SELL | 2012-06-06 | $45K | — | Filing → |